文献速递产科母胎医学

早孕期超声预测胎盘植入谱障碍三期超声分期及手术结局

Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

本研究为回顾性分析,纳入187例前置胎盘且有剖宫产或子宫手术史的孕妇,评估早孕期(5-7周)超声指标与中晚孕期胎盘植入谱(PAS)分期及不良手术结局的关系。结果显示,早孕期超声指标可独立预测PAS3期,联合晚孕期超声可分层手术风险。

要点

  • 早孕期超声指标可预测晚孕期PAS3期,AUC达0.92-0.94。
  • 联合早孕期超声与晚孕期分期可分层PAS患者手术风险。

核心结论

  • 早孕期超声评估剖宫产史孕妇可可靠预测PAS障碍的超声分期。
  • 联合早孕期与中晚孕期超声检查可分层PAS患者的手术风险。

研究设计与样本

  • 回顾性分析前瞻性收集的数据,纳入187例前置胎盘且有至少一次剖宫产或子宫手术史的孕妇,早孕期(5-7周)超声图像可获取。
  • 由两名对最终诊断和临床结局不知情的检查者评估孕囊位置与既往剖宫产瘢痕的关系,使用三种超声标记。

主要发现

  • 早孕期COS-1组中79.6%(95%CI 67.1-88.2%)在晚孕期超声为PAS3。
  • 早孕期孕囊种植于瘢痕龛内组中94.4%(95%CI 84.9-98.1%)在晚孕期超声为PAS3。
  • 早孕期孕囊位于子宫中线以下组中100%(95%CI 93.4-100%)在晚孕期超声为PAS3。
  • 多因素分析显示COS-1(OR 7.9,95%CI 4.0-15.5,P<0.001)、孕囊种植于龛内(OR 29.1,95%CI 8.1-104,P<0.001)、孕囊位于中线以下(OR 38.1,95%CI 12.0-121,P<0.001)与PAS3独立相关。
  • 不良手术结局发生于22/187例妊娠,在COS-1、孕囊种植于龛内、孕囊位于中线以下组中更常见(P<0.001)。

关键数值与推荐

  • 早孕期COS-1预测PAS3的AUC为0.94(95%CI 0.91-0.97)。
  • 早孕期孕囊种植于龛内预测PAS3的AUC为0.92(95%CI 0.89-0.96)。
  • 早孕期孕囊位于中线以下预测PAS3的AUC为0.92(95%CI 0.88-0.96)。
  • 多因素分析中,晚孕期超声诊断PAS3(OR 4.3,95%CI 2.1-17.3)、早孕期COS-1(OR 7.9,95%CI 4.0-15.5,P<0.001)、孕囊种植于龛内(OR 29.1,95%CI 8.1-79.0,P<0.001)、孕囊位于中线以下(OR 6.6,95%CI 3.9-16.2,P<0.001)与不良手术结局独立相关。

临床怎么用

  • 早孕期超声评估孕囊位置与剖宫产瘢痕关系可用于预测PAS障碍超声分期。
  • 联合早孕期与中晚孕期超声可分层PAS患者手术风险。
  • 文中提出「PAS高危三角」概念,便于视觉识别和应用三种方法预测风险,但需大型前瞻性研究验证。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore whether early first-trimester ultrasound can predict the third-trimester sonographic stage of placenta accreta spectrum (PAS) disorder and to elucidate whether combining first-trimester ultrasound findings with the sonographic stage of PAS disorder can stratify the risk of adverse surgical outcome in women at risk for PAS disorder. METHODS: This was a retrospective analysis of prospectively collected data from women with placenta previa, and at least one previous Cesarean delivery (CD) or uterine surgery, for whom early first-trimester (5-7 weeks' gestation) ultrasound images could be retrieved. The relationship between the position of the gestational sac and the prior CD scar was assessed using three sonographic markers for first-trimester assessment of Cesarean scar (CS) pregnancy, reported by Calí et al. (crossover sign (COS)), Kaelin Agten et al. (implantation of the gestational sac on the scar vs in the niche of the CS) and Timor-Tritsch et al. (position of the center of the gestational sac below vs above the midline of the uterus), by two different examiners blinded to the final diagnosis and clinical outcome. The primary aim of the study was to explore the association between first-trimester ultrasound findings and the stage of PAS disorder on third-trimester ultrasound. Our secondary aim was to elucidate whether the combination of first-trimester ultrasound findings and sonographic stage of PAS disorder can predict surgical outcome. Logistic regression analysis and area under the receiver-operating-characteristics curve (AUC) were used to analyze the data. RESULTS: One hundred and eighty-seven women with vasa previa were included. In this cohort, 79.6% (95% CI, 67.1-88.2%) of women classified as COS-1, 94.4% (95% CI, 84.9-98.1%) of those with gestational-sac implantation in the niche of the prior CS and 100% (95% CI, 93.4-100%) of those with gestational sac located below the uterine midline, on first-trimester ultrasound, were affected by the severest form of PAS disorder (PAS3) on third-trimester ultrasound. On multivariate logistic regression analysis, COS-1 (odds ratio (OR), 7.9 (95% CI, 4.0-15.5); P < 0.001), implantation of the gestational sac in the niche (OR, 29.1 (95% CI, 8.1-104); P < 0.001) and location of the gestational sac below the midline of the uterus (OR, 38.1 (95% CI, 12.0-121); P < 0.001) were associated independently with PAS3, whereas parity (P = 0.4) and the number of prior CDs (P = 0.5) were not. When translating these figures into diagnostic models, first-trimester diagnosis of COS-1 (AUC, 0.94 (95% CI, 0.91-0.97)), pregnancy implantation in the niche (AUC, 0.92 (95% CI, 0.89-0.96)) and gestational sac below the uterine midline (AUC, 0.92 (95% CI, 0.88-0.96)) had a high predictive accuracy for PAS3. There was an adverse surgical outcome in 22/187 pregnancies and it was more common in women with, compared to those without, COS-1 (P < 0.001), gestational-sac implantation in the niche (P < 0.001) and gestational-sac position below the uterine midline (P < 0.001). On multivariate logistic regression analysis, third-trimester ultrasound diagnosis of PAS3 (OR, 4.3 (95% CI, 2.1-17.3)) and first-trimester diagnosis of COS-1 (OR, 7.9 (95% CI, 4.0-15.5); P < 0.001), pregnancy implantation in the niche (OR, 29.1 (95% CI, 8.1-79.0); P < 0.001) and position of the sac below the uterine midline (OR, 6.6 (95% CI, 3.9-16.2); P < 0.001) were associated independently with adverse surgical outcome. When combining the sonographic coordinates of the three first-trimester imaging markers, we identified an area we call high-risk-for-PAS triangle, which may enable an easy visual perception and application of the three methods to prognosticate the risk for CS pregnancy and PAS disorder, although it requires validation in large prospective studies. CONCLUSIONS: Early first-trimester sonographic assessment of pregnancies with previous CD can predict reliably ultrasound stage of PAS disorder. Combination of findings on first-trimester ultrasound with second- and third-trimester ultrasound examination can stratify the surgical risk in women affected by a PAS disorder. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Calí G, Timor-Tritsch IE, Forlani F, et al. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol. 2020. PMID: 31788885. doi:10.1002/uog.21939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。